{"id":"NCT02819297","sponsor":"Braintree Laboratories","briefTitle":"BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-06","primaryCompletion":"2017-06","completion":"2017-06","firstPosted":"2016-06-30","resultsPosted":"2020-06-26","lastUpdate":"2020-07-27"},"enrollment":1020,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Constipation","Chronic Idiopathic Constipation","CIC"],"interventions":[{"type":"DRUG","name":"BLI400 Laxative","otherNames":[]},{"type":"DRUG","name":"BLI400 Placebo","otherNames":[]}],"arms":[{"label":"BLI400 Laxative","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study is to evaluate a daily dose of BLI400 Laxative for safety and efficacy versus placebo in constipated adults.","primaryOutcome":{"measure":"Treatment Response","timeFrame":"12 weeks","effectByArm":[{"arm":"BLI400 Laxative","deltaMin":77,"sd":null},{"arm":"Placebo","deltaMin":39,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":51,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":299},"commonTop":["Urinary tract infection","Flatulence"]}}